NCT06251440View on ClinicalTrials.gov

Initial Experience of Transabdominal Fetal Reduction in Nepal

CompletedOBSERVATIONAL

Enrollment

108

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions

In Vitro Fertilization

Interventions

DRUG

Fetal Reduction

Under ultrasound guidance, intracardiac injection of 0.2 to 3.0 ml of 15% weight/volume (2 miliequivalent/mililiter ) potassium chloride (KCl) was administered via transabdominal route

Trial Locations (1)

Nepal

Prajwal Dahal, Kathmandu

All Listed Sponsors

lead

Grande International Hospital, Nepal

OTHER

NCT06251440 - Initial Experience of Transabdominal Fetal Reduction in Nepal | Biotech Hunter | Biotech Hunter